Andere Sprachen BioVie Inc.

Aktien

A2PVAH

US09074F2074

BIVI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
0,4848 ^USD	-0,84 %		-0,35 %	-61,52 %

11.03.	BioVie Inc. kündigt Update der Pipeline und kurzfristige klinische Prioritäten an	CI
04.03.	Top Absteiger am Mittag	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints	25.04.
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation	18.04.
Lawsuit Notice: Investors who lost money with BioVie Inc. (NASDAQ: BIVI) shares should contact the Shareholders Foundation	26.03.
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioVie Inc. of Class Action Lawsuit and Upcoming Deadlines - BIVI	19.03.
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioVie Inc. (BIVI)	18.03.
Shareholders that lost money on BioVie Inc.(BIVI) should contact Levi & Korsinsky about pending Class Action - BIVI	15.03.
The Gross Law Firm Notifies Shareholders of BioVie Inc. (BIVI) of a Class Action Lawsuit and an Upcoming Deadline	14.03.
BIVI Investors Have Opportunity to Lead BioVie Inc. Securities Fraud Lawsuit	13.03.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie	13.03.
BIVI DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages BioVie Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - BIVI	13.03.
BIOVIE INC. CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by March 19, 2024	12.03.
Class Action Filed Against BioVie Inc. (BIVI) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky	12.03.
BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities	11.03.
BioVie Announces Pipeline Update and Near-Term Clinical Priorities	11.03.
BioVie Inc. Class Action: The Gross Law Firm Reminds BioVie Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - BIVI	11.03.
ROSEN, LEADING INVESTOR COUNSEL, Encourages BioVie Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - BIVI	10.03.
BIVI Investors Have Opportunity to Lead BioVie Inc. Securities Fraud Lawsuit	08.03.
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioVie Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - BIVI	07.03.
Contact The Gross Law Firm by March 19, 2024 Deadline to Join Class Action Against BioVie Inc.(BIVI)	07.03.
BioVie Inc. Announces Closing of Public Offering	06.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen BioVie Inc.

Aktien

A2PVAH

US09074F2074

BIVI

Andere Sprachen

Filter